Biomea Fusion, Inc. (BMEA) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 10 Buy, 3 Hold.
The consensus price target is $20.20 (low: $10.00, high: $40.00), representing an upside of 935.9% from the current price $1.95.
Analysts estimate Earnings Per Share (EPS) of $-3.89 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-3.83 vs est $-3.89 (beat +1.5%). 2025: actual $-1.18 vs est $-1.53 (beat +23%). Analyst accuracy: 84%.
BMEA Stock — 12-Month Price Forecast
$20.20
▲ +935.90% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Biomea Fusion, Inc., the average price target is $20.20, with a high forecast of $40.00, and a low forecast of $10.00.
The average price target represents a +935.90% change from the last price of $1.95.
Highest Price Target
$40.00
Average Price Target
$20.20
Lowest Price Target
$10.00
BMEA Analyst Ratings
Buy
Based on 13 analysts giving stock ratings to Biomea Fusion, Inc. in the past 3 months
EPS Estimates — BMEA
84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.83
vs Est –$3.89
▲ 1.5% off
2025
Actual –$1.18
vs Est –$1.53
▲ 29.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — BMEA
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
